PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

49 hedge funds and large institutions have $206M invested in VanEck Pharmaceutical ETF in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+6
Holders Change %
+13.95%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
13
Closed
5
Calls
$2.61M
Puts
$1.76M
Net Calls
+$852K
Net Calls Change
+$835K

Top Buyers

1
CS
Credit Suisse
Switzerland
+$72.7M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$38.8M
3
WWM
Western Wealth Management
Colorado
+$4.45M
4
TRCT
Tower Research Capital (TRC)
New York
+$793K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$713K

Top Sellers

1
Bank of America
Bank of America
North Carolina
-$51.5M
2
Wells Fargo
Wells Fargo
California
-$9.61M
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$5.74M
4
Goldman Sachs
Goldman Sachs
New York
-$1.28M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.03M
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– -$1.03M -18,133 Closed
FAAS
52
First Allied Advisory Services
California
– -$15K -274 Closed
MAM
53
Meeder Asset Management
Ohio
– -$9K -151 Closed
BEI
54
Benjamin Edwards Inc
Missouri
– -$1K -21 Closed
1 2
3